LMY-920 for Treatment of Relapsed or Refractory Myeloma

Clinical trial NCT05546723 · RECRUITING

Trial details

NCT number: NCT05546723
Sponsor: Luminary Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma, Refractory Multiple Myeloma in Relapse

Start date: 2024-03-13
Primary completion: 2025-07-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.